Closed Solicitation · DEPARTMENT OF HEALTH AND HUMAN SERVICES
AI Summary
The NIAID Centralized Sequencing Program seeks to acquire clinical long read genomics services to support genetic testing and variant interpretation for NIH patients. This RFP aims to purchase both symptom-driven and targeted long read sequencing analysis, contributing to disease understanding and patient care.
In support of clinical research, the NIAID Centralized Sequencing Program (CSP) is comprehensive program that obtains genetic testing, harmonizes phenotypic and genomic data, performs variant interpretation, and provides clinically validated results for patients enrolled in protocols at the NIH Clinical Center. The goal of the NIAID Centralized Sequencing Program is both to contribute to the understanding of underlying genetic etiology of disease and to address the clinical need for genomic evaluations.
The purpose of this acquisition is to support the mission of DIR to obtain genetic testing for the NIAID CSP. The objective is to purchase both symptom-driven long read sequencing analysis and targeted long read sequencing. The results of this testing will have direct implications for the care of NIH patients and for the discovery of disease mechanisms.
The scope of this effort includes the services and industry knowledge necessary to provide long read sequencing as specified in this SOW.
CLINICAL LONG READ GENOMICS SERVICES FOR THE NIAID CENTRALIZED SEQUENCING PROGRAM is a federal acquisition solicitation issued by DEPARTMENT OF HEALTH AND HUMAN SERVICES. Review the full description, attachments, and submission requirements on SamSearch before the response deadline.
SamSearch Platform
AI-powered intelligence for the right opportunities, the right leads, and the right time.